Millipore Sigma, one of the largest suppliers of medical research products, will start adding a temporary tariff surcharge to all product orders shipped to the U.S.

Millipore’s gene therapy production efforts began in 1997, predating its acquisition by Merck KGaA by 13 years. In 2021, the companies expanded their gene therapy production campus in Carlsbad ...

Merck, a leading science and technology company, today announced Neoclease as the winner of the 2025 North American Advance ...

Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio in a $600m (€500m) deal. The move aims to enhance Merck’s ...